In context
GHRP-6 was investigated in early studies measuring growth-hormone responses in adults and children with differing degrees of growth-hormone deficiency. [1]
At a glance
- Type
- Peptide / related clinical research
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- The outcome measured was hormone release. Those experiments should not be interpreted as evidence of muscle gain or as a treatment plan for someone without the studied condition.
How to interpret this evidence
The outcome measured was hormone release. Those experiments should not be interpreted as evidence of muscle gain or as a treatment plan for someone without the studied condition. [1]
Safety and clinical context
The evidence described here does not establish safety for unsupervised use. Product identity, route, formulation, interactions and long-term effects cannot be inferred from a study category.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.
- GH releasing peptides--structure and kinetics. pubmed.ncbi.nlm.nih.gov